FDA Approved: LIVTENCITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LIVTENCITY (maribavir) submitted by Takeda Pharmaceuticals America, Inc., resulting in an updated NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• LIVTENCITY (MARIBAVIR)

Snippet

SUPPL AP for LIVTENCITY (MARIBAVIR)